Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care
- 1 July 2009
- journal article
- practice guideline
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 40 (7), 2635-2660
- https://doi.org/10.1161/strokeaha.109.192361
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective studyThe Lancet Neurology, 2008
- Empirical Characteristics of Litigation Involving Tissue Plasminogen Activator and Ischemic StrokeAnnals of Emergency Medicine, 2008
- Neurology residency training in the US and PolandNature Clinical Practice Neurology, 2007
- Private Payer Reimbursement for Telemedicine Services in The United StatesTelemedicine and e-Health, 2007
- Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke CentersStroke, 2006
- Thrombolysis (Tissue Plasminogen Activator) in StrokeStroke, 2006
- Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United StatesStroke, 2005
- Survey of Emergency Physicians About Recombinant Tissue Plasminogen Activator for Acute Ischemic StrokeAnnals of Emergency Medicine, 2005
- Teleneurology to Improve Stroke Care in Rural AreasStroke, 2003
- Telemedicine in Emergency Evaluation of Acute StrokeStroke, 2003